Sort
30,917 grants matching “tumor microenvironment”
TGF-betas in breast cancer progression
$1,272,987Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Analysis of Pathways that Suppress or Accelerate Premalignant Progression and Ma
$1,269,850Stuart H. Yuspa · Basic Sciences · Z01 · FY2007 · CA
Role of the microbiota in regulating the mononuclear phagocyte system
$1,269,731Romina Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Modulation of Therapeutic Response
$1,269,616James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
The role of Galpha13 signaling in suppression of lymphoma
$1,265,415Jagan Muppidi · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC
$1,264,894Andrew N Lane · University Of Kentucky · P01 · FY2017 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,263,868Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC
$1,263,861Andrew N Lane · University Of Kentucky · P01 · FY2015 · CA
Role of mouse microbiome in cancer and inflammation
$1,263,350Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
NF Center: from animal models to therapeutics
$1,263,336Luis F Parada · Ut Southwestern Medical Center · P50 · FY2012 · NS
A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020
$1,262,498Elias Sayour · University Of Florida · R01 · FY2022 · FD
Preclinical Mouse Models of Thyroid Cancer
$1,261,890Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers
$1,257,340Laura J Esserman · University Of California, San Francisco · U01 · FY2018 · CA
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment
$1,255,581Jyothi Rengarajan · Emory University · R01 · FY2022 · AI
A High Content Screening Platform for High Throughput, High Content Imaging and Analysis
$1,254,909Patricia Helen McDonald · H. Lee Moffitt Cancer Ctr & Res Inst · S10 · FY2022 · OD
The study of stem cell and neuro-vascular development
$1,254,797Yosuke Mukoyama · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Therapeutic targets and novel anticancer agents for endocrine cancers
$1,254,239Naris Nilubol · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Pleitrophin as a Mitigator of Radiation Induced Hematopoietic Syndrome
$1,253,568John P Chute · Duke University · U19 · FY2012 · AI
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$1,252,261Robert Wiltrout · Basic Sciences · Z01 · FY2007 · CA
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,252,072Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Multiscale Analysis of Immune Responses
$1,248,975Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Mechanobiology
$1,247,864Alexander Cartagena-Rivera · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2020 · EB
Cellular In vivo Imaging
$1,247,547Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
NF Center: from animal models to therapeutics
$1,244,799Luis F Parada · Ut Southwestern Medical Center · P50 · FY2013 · NS
Single-cell DNA methylation analysis of human cancer
$1,244,669Kenneth Aldape · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA